Register entry

Titan Kogyo , Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
8
Live patents
0
Countries
1
Base
Japan
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
TITAN KOGYO ,LTD.Registrant: Titan Kogyo , Ltd.1727-1 , TSUMAZAKIGAISAKU, UBE, YAMAGUCHI 759-0204, Japan (JPN)Active ingredient (API) manufacture3009155994706280823
Catalogue

Drug listings by form and route

8

8 active NDC listings: 7 drug for further processing, 1 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 7, BULK INGREDIENT 1.

Dosage formNDCs
powder8
RouteNDCs
Labeller name on the listingNDCs
titan kogyo, ltd.8
Catalogue

Marketed products

8
BrandGeneric nameForm / routeNDC
-Titanium dioxidepowder69079-152DRUG FOR FURTHER PROCESSING
-Titanium dioxidepowder69079-153DRUG FOR FURTHER PROCESSING
-Titanium dioxidepowder69079-154DRUG FOR FURTHER PROCESSING
-Titanium dioxidepowder69079-155DRUG FOR FURTHER PROCESSING
-Titanium dioxidepowder69079-156DRUG FOR FURTHER PROCESSING
-Titanium dioxidepowder69079-161DRUG FOR FURTHER PROCESSING
-Titanium dioxidepowder69079-181BULK INGREDIENT
-Titanium dioxidepowder69079-182DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

2
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Titan Kogyo , Ltd. FDA approved?
Titan Kogyo , Ltd. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Titan Kogyo , Ltd.'s drugs manufactured?
The FDA register lists UBE. Registered operations: active ingredient (API) manufacture.
What drugs does Titan Kogyo , Ltd. make?
8 products are listed under Titan Kogyo , Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.